Education
About Us
Working with TipRanks
Follow Us
Bioharvest Sciences, Inc. (BHST)
:BHST
BHST Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.66 - $7.99
Previous CloseN/A
VolumeN/A
Average Volume (3M)7.95K
Market Cap
$133.22M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.47
Next Earnings
Sep 01, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding17,327,717
10 Day Avg. Volume11,042
30 Day Avg. Volume7,954
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$13.00Price Target Upside71.05% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Bulls Say, Bears Say
Bulls Say
Product ExpansionThe company is expecting revenue contribution from five products by the end of 2025, demonstrating product expansion and diversification.
Revenue GrowthBioHarvest Sciences Inc. reported revenues of $7.9M, showing a 47% year-over-year increase, indicating strong growth.
Technological AdvancementsThe company is leveraging AI across multiple fronts to keep costs contained and improve operations, enhancing its competitive advantage.
Bears Say
Capital NeedsThe company may need to raise capital before the end of 1Q25 to pay down its convertible loans and fund operations for 1H25.
Market UnderappreciationBioHarvest’s market opportunity and expertise in botanical synthesis are significantly underappreciated, trading at a lower multiple compared to competitors, indicating potential value realization for investors.
Revenue GuidanceManagement introduced 2Q25 revenue guidance of at least $8.5M, which is below prior consensus of $8.9M and a prior estimate of $9.2M.
BioHarvest Sciences News
BHST FAQ
What was Bioharvest Sciences, Inc.’s price range in the past 12 months?
Bioharvest Sciences, Inc. lowest stock price was $4.66 and its highest was $7.99 in the past 12 months.
What is Bioharvest Sciences, Inc.’s market cap?
Bioharvest Sciences, Inc.’s market cap is $133.22M.
When is Bioharvest Sciences, Inc.’s upcoming earnings report date?
Bioharvest Sciences, Inc.’s upcoming earnings report date is Sep 01, 2025 which is in 30 days.
How were Bioharvest Sciences, Inc.’s earnings last quarter?
Bioharvest Sciences, Inc. released its earnings results on May 15, 2025. The company reported -$0.13 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.13.
Is Bioharvest Sciences, Inc. overvalued?
According to Wall Street analysts Bioharvest Sciences, Inc.’s price is currently Undervalued.
Does Bioharvest Sciences, Inc. pay dividends?
Bioharvest Sciences, Inc. does not currently pay dividends.
What is Bioharvest Sciences, Inc.’s EPS estimate?
Bioharvest Sciences, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bioharvest Sciences, Inc. have?
Bioharvest Sciences, Inc. has 17,327,717 shares outstanding.
What happened to Bioharvest Sciences, Inc.’s price movement after its last earnings report?
Bioharvest Sciences, Inc. reported an EPS of -$0.13 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.089%.
Which hedge fund is a major shareholder of Bioharvest Sciences, Inc.?
Currently, no hedge funds are holding shares in BHST
BioHarvest Sciences Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$13.00 (71.05% Upside)
$13.00 (71.05% Upside)
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.30%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
105.92%
Trailing 12-Months
Company Description
Bioharvest Sciences, Inc.
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.
BHST Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a strong performance with significant revenue growth, improved gross margins, and successful product expansions. However, the company faced challenges with increased operating expenses and a continued net loss, though these were offset by strategic growth initiatives and financial improvements.Read More>BHST Stock 12 Month Forecast
Average Price Target
$13.00
▲(71.05%Upside)
Technical Analysis
Ownership Overview
0.09%
Insiders
―
Mutual Funds
0.53% Other Institutional Investors
99.47% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---